ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
129.480,89
0,21%
S&P 500
5.187,67
0,00%
US Dollar vs BRL
5,0911
0,03%
Bitcoin
60.948,20
-0,40%
Brent Oil
84,03
0,56%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Anixa Biosciences Inc (ANIX)

  7. Anixa Biosciences Inc (ANIX) Notícias

ANIX

Anixa Biosciences (ANIX)

Anixa Biosciences Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:ANIX
DataHoraFonteTítuloCódigoCompanhia
08/05/202409:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANIXAnixa Biosciences Inc
08/05/202409:25PR Newswire (US)Anixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer VaccinesNASDAQ:ANIXAnixa Biosciences Inc
06/05/202409:05PR Newswire (US)Anixa Biosciences CEO Featured on "Target: Cancer Podcast" by Oncologist Dr. Sanjay JunejaNASDAQ:ANIXAnixa Biosciences Inc
30/04/202408:45PR Newswire (US)Anixa Biosciences to Participate in the Sidoti Micro-Cap Virtual Conference on May 8 & 9, 2024NASDAQ:ANIXAnixa Biosciences Inc
18/04/202409:20PR Newswire (US)Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory BoardNASDAQ:ANIXAnixa Biosciences Inc
14/03/202409:45PR Newswire (US)Anixa Biosciences 2024 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested PartiesNASDAQ:ANIXAnixa Biosciences Inc
11/03/202409:00PR Newswire (US)Anixa Biosciences Announces Presentation at 24th Annual World Vaccine CongressNASDAQ:ANIXAnixa Biosciences Inc
12/02/202409:30PR Newswire (US)Anixa Biosciences Initiates Dosing in Second Cohort of Ovarian Cancer CAR-T Clinical TrialNASDAQ:ANIXAnixa Biosciences Inc
08/02/202418:15Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ANIXAnixa Biosciences Inc
29/01/202410:50PR Newswire (US)Anixa Biosciences Announces Participation in 2024 NeauxCancer Oncology ConferenceNASDAQ:ANIXAnixa Biosciences Inc
23/01/202409:55PR Newswire (US)Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine TechnologyNASDAQ:ANIXAnixa Biosciences Inc
16/01/202421:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIXAnixa Biosciences Inc
16/01/202419:29Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ANIXAnixa Biosciences Inc
16/01/202418:43Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ANIXAnixa Biosciences Inc
16/01/202418:30Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ANIXAnixa Biosciences Inc
10/01/202411:00PR Newswire (US)Anixa Biosciences to Present at Sidoti Micro-Cap Virtual Conference on January 17, 2024NASDAQ:ANIXAnixa Biosciences Inc
14/12/202309:15PR Newswire (US)Anixa Biosciences to Present at Biotech Showcase 2024NASDAQ:ANIXAnixa Biosciences Inc
06/12/202320:00PR Newswire (US)Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer VaccineNASDAQ:ANIXAnixa Biosciences Inc
06/12/202318:05PR Newswire (US)Anixa Biosciences to Host Conference Call This Evening to Discuss Positive New Data from Ongoing Phase 1 Study of Breast Cancer VaccineNASDAQ:ANIXAnixa Biosciences Inc
27/11/202310:30PR Newswire (US)Anixa Biosciences Announces European Patent on Ovarian Cancer Vaccine TechnologyNASDAQ:ANIXAnixa Biosciences Inc
31/10/202309:30PR Newswire (US)Anixa Biosciences to Present at the Ovarian Cancer Research Alliance (OCRA) Ovarian Cancer National ConferenceNASDAQ:ANIXAnixa Biosciences Inc
23/10/202309:30PR Newswire (US)Anixa Biosciences Appoints Accomplished Medical Oncologist and Biotechnology Executive, Dr. Mark A. Goldberg, to Cancer Business Advisory BoardNASDAQ:ANIXAnixa Biosciences Inc
13/10/202309:30PR Newswire (US)Anixa Biosciences Completes Treatment of First Patient Cohort in Ovarian Cancer CAR-T Clinical TrialNASDAQ:ANIXAnixa Biosciences Inc
03/10/202309:30PR Newswire (US)Anixa Biosciences Announces Issuance of Additional U.S. Patent for Ovarian Cancer Vaccine TechnologyNASDAQ:ANIXAnixa Biosciences Inc
19/09/202309:30PR Newswire (US)Anixa Biosciences Establishes Cancer Business Advisory BoardNASDAQ:ANIXAnixa Biosciences Inc
06/09/202317:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ANIXAnixa Biosciences Inc
31/08/202309:30PR Newswire (US)Anixa Biosciences to Participate in September Investor ConferencesNASDAQ:ANIXAnixa Biosciences Inc
28/08/202309:30PR Newswire (US)Anixa Biosciences Announces Treatment of Third Patient in Ovarian Cancer CAR-T Clinical TrialNASDAQ:ANIXAnixa Biosciences Inc
14/08/202309:30PR Newswire (US)Anixa Biosciences Announces Invited Presentation on Ovarian Cancer CAR-T Therapy at the 8th Annual CAR-TCR SummitNASDAQ:ANIXAnixa Biosciences Inc
07/08/202309:30PR Newswire (US)Anixa Biosciences Announces Opening of Enrollment for Keytruda® Arm in Ongoing Breast Cancer Vaccine Clinical TrialNASDAQ:ANIXAnixa Biosciences Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:ANIX

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
COGN3
COGNA ON
BOV
OIBR3
OI ON
BOV
BHIA3
Grupo Casas Bahia ON
BOV
VVEO3
CM Hospitalar ON
BOV
JHSF3
JHSF PART ON
BOV
BRKM5
BRASKEM PNA
BOV
PRIO3
PETRORIO ON
BOV
TELB4
TELEBRAS PN
BOV
SGPS3
SPRINGS ON
BOV
ENAT3
ENAUTA ON
BOV
HBRE3
HBR Realty Empreendiment... ON
BOV
IFCM3
Infracommerce Caxaas ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados